Patrys Limited

ASX:PAB ISIN:AU000000PAB9

Patrys Limited (ASX:PAB) is an Australia-based company. The principal activity of the Company is to develop natural human antibody based therapeutic products for the treatment of cancer and other diseases. 
 
    

查看其它语言版本

新闻

2010年8月2日澳洲股市

🕔8/2/2010 1:30:45 PM 12381

本周澳洲股市未受华尔街平淡带动的影响,开盘略涨。早盘时,黄金类和金融类股票扬升。基准指数S&P/ASX200 上扬15.2点至4508.7点,综合指数上扬14 点至4521.4点。

阅读全文
###

32,543 公司背景浏览

  • 本页浏览人次: (过去7日: 12) (过去30日: 59) (自发布以来: 6927) 

公司详细信息

    主要部门
  • 医疗-制药 
  • 支柱产业
  • None 

更多新闻纪录

  • 2024/10/30: Appendix 4C - Quarterly - 30 September 2024*
  • 2024/10/21: Notice of Annual General Meeting/Proxy Form*
  • 2024/10/14: Notification of cessation of securities - PAB*
  • 2024/10/02: PAT-DX1 clinical development update*
  • 2024/09/20: PAT-DX1 GMP specification testing update*
  • 2024/08/29: PAT-DX1 GMP specification testing update*
  • 2024/08/23: Appendix 4G and Corporate Governance Statement*
  • 2024/08/23: Appendix 4E and 2024 Annual Report*
  • 2024/07/29: Further update on PAT-DX1 GMP manufacturing run*
  • 2024/07/23: Appendix 4C - Quarterly - 30 June 2024*
*refer to company website